COPD Exacerbation Acute Clinical Trials

8 recruiting

Frequently Asked Questions

Common questions about COPD Exacerbation Acute clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Neuromuscular Electrical Stimulation in COPD/Community Acquired Pneumonia

COPD Exacerbation AcuteCommunity-acquired Pneumonia
University of Vermont8 enrolled1 locationNCT05452226
Recruiting
Phase 4

Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease

COPD ExacerbationCOPD Exacerbation Acute
Central Denmark Region1,888 enrolled1 locationNCT05703919
Recruiting
Not Applicable

The Reducing REVISITS Study: A Cluster RCT

COPDCOPD Exacerbation Acute
University of Chicago24 enrolled1 locationNCT05568043
Recruiting

Assessing Optimal Inhaler Strategies During Acute Exacerbations of COPD (AECOPDs) Using Oscillometry

COPDCOPD Exacerbation Acute
McGill University Health Centre/Research Institute of the McGill University Health Centre43 enrolled1 locationNCT06495047
Recruiting
Not Applicable

The Effect of Airway and Chest Wall Oscillation on Respiratory Functions in COPD Patients in Acute Exacerbation

COPD Exacerbation Acute
Saglik Bilimleri Universitesi27 enrolled1 locationNCT06274957
Recruiting
Not Applicable

Multiparametric Home Telemonitoring of Patients With Chronic Obstructive Pulmonary Disease Exacerbation

COPDCOPD Exacerbation Acute
University of Trieste60 enrolled1 locationNCT06331416
Recruiting

Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting

AsthmaVasculitisInflammatory Disease+2 more
Imperial College London120 enrolled1 locationNCT05012033
Recruiting

COPD-ICU Multicentre Prospective Observational Register

COPD Exacerbation Acute
Versailles Hospital500 enrolled1 locationNCT05734365